A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
09 2023
Historique:
revised: 03 05 2023
received: 29 12 2022
accepted: 19 05 2023
pmc-release: 01 09 2024
medline: 11 9 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Nonhematopoietic lymph node stromal cells (LNSCs) regulate lymphocyte trafficking, survival, and function for key roles in host defense, autoimmunity, alloimmunity, and lymphoproliferative disorders. However, the study of LNSCs in human diseases is complicated by a dependence on viable lymphoid tissues, which are most often excised prior to establishment of a specific diagnosis. Here, we demonstrate that cryopreservation can be used to bank lymphoid tissue for the study of LNSCs in human disease. Using human tonsils and lymph nodes (LN), lymphoid tissue fragments were cryopreserved for subsequent enzymatic digestion and recovery of viable nonhematopoietic cells. Flow cytometry and single-cell transcriptomics identified comparable proportions of LN stromal cell types in fresh and cryopreserved tissue. Moreover, cryopreservation had little effect on transcriptional profiles, which showed significant overlap between tonsils and LN. The presence and spatial distribution of transcriptionally defined cell types were confirmed by in situ analyses. Our broadly applicable approach promises to greatly enable research into the roles of LNSCs in human disease.

Identifiants

pubmed: 37366295
doi: 10.1002/eji.202250362
pmc: PMC10529925
mid: NIHMS1918857
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2250362

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007439
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI091627
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009140
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141408
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023 Wiley-VCH GmbH.

Références

Leukemia. 2019 Apr;33(4):1035-1038
pubmed: 30607019
Sci Rep. 2017 Jul 20;7(1):6031
pubmed: 28729663
Immunity. 2018 May 15;48(5):1014-1028.e6
pubmed: 29752062
Blood. 2017 Mar 23;129(12):1646-1657
pubmed: 28087540
Nat Biotechnol. 2022 Feb;40(2):245-253
pubmed: 34594043
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19802-7
pubmed: 24248345
Immunity. 2021 Aug 10;54(8):1788-1806.e7
pubmed: 34166622
Gastroenterology. 2008 Apr;134(4):1028-37
pubmed: 18395084
Semin Immunol. 2018 Feb;35:48-58
pubmed: 29198601
Nat Commun. 2019 Apr 15;10(1):1739
pubmed: 30988302
Nat Cell Biol. 2022 Apr;24(4):565-578
pubmed: 35332263
J Exp Med. 2010 Apr 12;207(4):689-97
pubmed: 20308362
J Clin Invest. 2017 Apr 3;127(4):1574-1588
pubmed: 28319044
Sci Immunol. 2018 Aug 10;3(26):
pubmed: 30097537
Nat Immunol. 2019 Dec;20(12):1668-1680
pubmed: 31636464
PLoS Biol. 2018 Sep 4;16(9):e2005046
pubmed: 30180168
Science. 2016 Jun 24;352(6293):1586-90
pubmed: 27339989
Front Immunol. 2011 Sep 12;2:35
pubmed: 22566825
Mod Pathol. 2014 Jun;27(6):823-31
pubmed: 24201121
Hematol Oncol Clin North Am. 2018 Feb;32(1):11-21
pubmed: 29157613
Nat Immunol. 2021 Apr;22(4):510-519
pubmed: 33707780
Nat Immunol. 2021 May;22(5):571-585
pubmed: 33903764
Science. 2022 Jun 3;376(6597):eabo0510
pubmed: 35549310
Immunity. 2019 Sep 17;51(3):561-572.e5
pubmed: 31402260
Immunity. 2013 May 23;38(5):1013-24
pubmed: 23623380
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
J Immunol. 2021 Jan 15;206(2):257-263
pubmed: 33397739
PLoS One. 2016 Dec 1;11(12):e0167555
pubmed: 27907202
Nat Biotechnol. 2020 Jun;38(6):737-746
pubmed: 32341560
Sci Immunol. 2022 Jan 07;7(67):eabj0641
pubmed: 34995096
Nat Immunol. 2020 Jun;21(6):649-659
pubmed: 32424359
J Exp Med. 2021 Oct 4;218(10):
pubmed: 34424268
Leukemia. 2020 Oct;34(10):2592-2606
pubmed: 32704161
Nat Immunol. 2016 Dec;17(12):1388-1396
pubmed: 27798617
PLoS Biol. 2020 Apr 6;18(4):e3000704
pubmed: 32251437
Nat Immunol. 2012 Apr 01;13(5):499-510
pubmed: 22466668

Auteurs

Joshua D Brandstadter (JD)

Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Angelina De Martin (A)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Mechthild Lϋtge (M)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Antonio Ferreira (A)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Brian T Gaudette (BT)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Yves Stanossek (Y)

Department of Otorhinolaryngology, Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Shumei Wang (S)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Michael V Gonzalez (MV)

Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Edward Camiolo (E)

Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Gerald Wertheim (G)

Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Bridget Austin (B)

Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

David Allman (D)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Adam Bagg (A)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Megan S Lim (MS)

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David C Fajgenbaum (DC)

Center for Cytokine Storm Treatment and Laboratory, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Jon C Aster (JC)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Burkhard Ludewig (B)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Ivan Maillard (I)

Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH